Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study.

M V T Krishna MohanArpitkumar PrajapatiRushabh KothariSrikrishna MandalRanganatha Rao SrikanthRajnish NagarkarShriram KhaneAyyagari SantaDisha Dadke

Published in: Clinical drug investigation (2024)

CTRI Number: CTRI/2020/04/024456.

Keyphrases